All In Biotech

Drug Trial Radar · NCT00702117

Ajmaline Utilization in the Diagnosis and Treatment of Cardiac Arrhythmias

Last checked: Nov 19, 2026Latest source record: Dec 15, 2010 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 123 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

123

Actual

Start

Jun 2008

Primary completion

Jan 2010

Study completion Jan 2010

Sponsor

Lead sponsor
Hospital Clinic of BarcelonaAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jun 20, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 10 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study evaluates 3 different populations: It is an open, randomized, parallel-group study comparing the effectiveness of intravenous (iv) ajmaline with currently used antiarrhythmic drugs in the acute treatment of : 1. recent-onset atrial fibrillation versus iv flecainide 2. sustained monomorphous ventricular tachycardia versus iv procainamide The study also evaluates in an open, randomized, crossover study, the use of iv ajmaline versus iv flecainide in the diagnosis of Brugada syndrome

Conditions

  • Atrial Fibrillation
  • Tachycardia, Ventricular
  • Brugada Syndrome

Interventions

  • flecainideDrug

    2 mg/kg iv in 10 minutes

  • ajmalineDrug

    1 mg/kg iv in 10 minutes

  • procainamideDrug

    10 mg/kg iv in 10 minutes

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of patients with reversion of atrial fibrillationTime frame: 1 hour
  2. Proportion of patients with reversion of ventricular tachycardiaTime frame: 15 min
  3. Proportion of subjects developing EKG pattern diagnostic of Brugada Sd. after provocation test.Time frame: 1 hour

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Servicio de Cardiología, Hospital Clínic

    Barcelona, Barcelona, Spain

  • Hospital Donostia

    Donostia / San Sebastian, Guipuzcoa, Spain

  • Hospital Puerta de Hierro

    Madrid, Madrid, Spain

  • Hospital La Fe

    Valencia, Valencia, Spain

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.